ArticleMedicine2026
Systematic analysis and projections of the global and regional burden of meningitis among children under 5 years, 1990 to 2021, with forecasts to 2050.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Using Global Burden of Disease 2021 estimates, we characterized long-term trends (1990-2021), age-specific patterns, and socioeconomic/geographic disparities in the global meningitis burden, and descriptively benchmarked country-level burden relative to development level using frontier analysis. We analyzed incidence, mortality, prevalence, and disability-adjusted life years using age-standardized rates across locations and time. We further assessed temporal trends, age-specific patterns, socioeconomic and geographic inequalities, decomposition of burden changes, and development-conditioned frontier benchmarks, and generated projections to 2050 using Bayesian age-period-cohort forecasting models. From 1990 to 2021, the global meningitis burden among children under 5 years declined across major indicators. Projections suggested continued overall reductions to 2050 under the continuation of observed historical patterns. Despite this progress, the burden remained unevenly distributed. Neonates had the highest burden across major metrics, and low-SDI settings continued to experience substantially higher incidence, mortality, and disability-adjusted life year rates than high-SDI settings. Inequality analyses further indicated that relative disparities persisted over time. The global burden of meningitis among children under 5 years has declined and is projected to continue decreasing. However, the remaining burden is concentrated among neonates and in lower-SDI settings. Because these patterns were identified consistently across age-specific, SDI-stratified, and inequality analyses, sustained progress will require continued burden reduction together with equity-oriented prevention, diagnostic access, and newborn-care strategies targeted to neonates and lower-SDI high-burden settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.